Johnson & Johnson’sJanssen Biotech Inc. alleges that a biosimilar version of Stelara proposed by Amgen Inc. infringes two patents for the ulcerative colitis treatment, whose US sales were nearly $6 billion in 2021.
A coalition of health centers has dropped a lawsuit against the federal government over its failure to provide a venue for fighting pharmaceutical companies they say are overcharging them for certain drugs.
The Texas Medical Association filed a second lawsuit against the Department of Health and Human Services over its regulation outlining the process for settling payment disputes between health-care providers and insurers under the No Surprises Act.
US regulators said Wednesday that Eli Lilly & Co.’s monoclonal antibody treatment for Covid-19 is no longer authorized for emergency use because it’s not likely to work against infections caused by the forms of omicron that are dominant across the country.
Blue Cross & Blue Shield of Massachusetts Inc. received preliminary federal court approval Wednesday for a class settlement in which it agreed to pay between $5,000 and $88,875 to individual families seeking coverage for their children’s mental health services.